Prostanoids as pharmacological targets in COPD and asthma
- 8 March 2006
- journal article
- review article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 533 (1-3), 89-100
- https://doi.org/10.1016/j.ejphar.2005.12.058
Abstract
No abstract availableKeywords
This publication has 136 references indexed in Scilit:
- Clinical implications of airway inflammation in mild intermittent asthmaAnnals of Allergy, Asthma & Immunology, 2004
- Prostaglandin F synthaseProstaglandins & Other Lipid Mediators, 2002
- Thromboxane A2 and related prostaglandins in airwaysFundamental & Clinical Pharmacology, 1997
- Increased renal formation of thromboxane A 2 and prostaglandin F 2α in heart failureAmerican Heart Journal, 1997
- Nonenzymatic Free Radical-catalyzed Generation of Thromboxane-like Compounds (Isothromboxanes) in VivoPublished by Elsevier BV ,1996
- Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhageSurgical Neurology, 1991
- Clinical Implications of Prostaglandin and Thromboxane A2FormationNew England Journal of Medicine, 1988
- Release of Prostaglandin D2into Human Airways during Acute Antigen ChallengeNew England Journal of Medicine, 1986
- The Bronchoconstrictor Effect of Inhaled Prostaglandin D2 in Normal and Asthmatic MenNew England Journal of Medicine, 1984
- Increased Production of Prostaglandin D2 in Patients with Systemic MastocytosisNew England Journal of Medicine, 1980